Previous Article | Next Article 
Molecular and Cellular Biology, August 2001, p. 5389-5395, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5389-5395.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Disruption of
-Glutamyl Leukotrienase Results in
Disruption of Leukotriene D4 Synthesis In Vivo and
Attenuation of the Acute Inflammatory Response
Zheng-Zheng
Shi,1
Bing
Han,1
Geetha M.
Habib,1
Martin M.
Matzuk,1,2,3 and
Michael W.
Lieberman1,2,*
Departments of
Pathology,1 Molecular and Cellular
Biology,2 and Molecular and Human
Genetics,3 Baylor College of Medicine,
Houston, Texas 77030
Received 3 April 2001/Accepted 23 May 2001
To study the function of
-glutamyl leukotrienase (GGL), a newly
identified member of the
-glutamyl transpeptidase (GGT) family, we
generated null mutations in GGL (GGLtm1) and in both GGL
and GGT (GGLtm1-GGTtm1) by a serial targeting
strategy using embryonic stem cells. Mice homozygous for
GGLtm1 show no obvious phenotypic changes. Mice deficient
in both GGT and GGL have a phenotype similar to the GGT-deficient mice,
but ~70% of these mice die before 4 weeks of age, at least 2 months earlier than mice deficient only in GGT. These double-mutant mice are
unable to cleave leukotriene C4 (LTC4) to
LTD4, indicating that this conversion is completely
dependent on the two enzymes, and in some organs (spleen and uterus)
deletion of GGL alone abolished more than 90% of this activity. In an
experimental model of peritonitis, GGL alone is responsible for the
generation of peritoneal LTD4. Further, during the
development of peritonitis, GGL-deficient mice show an attenuation in
neutrophil recruitment but not of plasma protein influx. These findings
demonstrate an important role for GGL in the inflammatory response and
suggest that LTC4 and LTD4 have distinctly
different functions in the inflammatory process.
*
Corresponding author. Mailing address: Department of
Pathology, One Baylor Plaza, Baylor College of Medicine, Houston, TX 77030. Phone: (713) 798-6501. Fax: (713) 798-6001. E-mail:
mikel{at}bcm.tmc.edu.
Molecular and Cellular Biology, August 2001, p. 5389-5395, Vol. 21, No. 16
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5389-5395.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhang, H., Forman, H. J.
(2009). Redox Regulation of {gamma}-Glutamyl Transpeptidase. Am. J. Respir. Cell Mol. Bio.
41: 509-515
[Abstract]
[Full Text]
-
Paruchuri, S., Tashimo, H., Feng, C., Maekawa, A., Xing, W., Jiang, Y., Kanaoka, Y., Conley, P., Boyce, J. A.
(2009). Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. JEM
206: 2543-2555
[Abstract]
[Full Text]
-
Maekawa, A., Balestrieri, B., Austen, K. F., Kanaoka, Y.
(2009). GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc. Natl. Acad. Sci. USA
106: 11685-11690
[Abstract]
[Full Text]
-
Buczynski, M. W., Dumlao, D. S., Dennis, E. A.
(2009). Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid Res.
50: 1015-1038
[Abstract]
[Full Text]
-
Martin, M. N., Saladores, P. H., Lambert, E., Hudson, A. O., Leustek, T.
(2007). Localization of Members of the {gamma}-Glutamyl Transpeptidase Family Identifies Sites of Glutathione and Glutathione S-Conjugate Hydrolysis. Plant Physiol.
144: 1715-1732
[Abstract]
[Full Text]
-
Murai, A., Abe, M., Hayashi, Y., Sakata, N., Katsuragi, T., Tanaka, K.
(2005). Comparison Study between the Mechanisms of Allergic Asthma Amelioration by a Cysteinyl-Leukotriene Type 1 Receptor Antagonist Montelukast and Methylprednisolone. J. Pharmacol. Exp. Ther.
312: 432-440
[Abstract]
[Full Text]
-
Peters-Golden, M., Canetti, C., Mancuso, P., Coffey, M. J.
(2005). Leukotrienes: Underappreciated Mediators of Innate Immune Responses. J. Immunol.
174: 589-594
[Abstract]
[Full Text]
-
Beller, T. C., Maekawa, A., Friend, D. S., Austen, K. F., Kanaoka, Y.
(2004). Targeted Gene Disruption Reveals the Role of the Cysteinyl Leukotriene 2 Receptor in Increased Vascular Permeability and in Bleomycin-induced Pulmonary Fibrosis in Mice. J. Biol. Chem.
279: 46129-46134
[Abstract]
[Full Text]
-
Kanaoka, Y., Boyce, J. A.
(2004). Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses. J. Immunol.
173: 1503-1510
[Abstract]
[Full Text]
-
Beller, T. C., Friend, D. S., Maekawa, A., Lam, B. K., Austen, K. F., Kanaoka, Y.
(2004). Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl. Acad. Sci. USA
101: 3047-3052
[Abstract]
[Full Text]
-
Zaitsu, M., Hamasaki, Y., Tsuji, K., Matsuo, M., Fujita, I., Aoki, Y., Ishii, E., Kohashi, O.
(2003). Dexamethasone accelerates catabolism of leukotriene C4 in bronchial epithelial cells. Eur Respir J
22: 35-42
[Abstract]
[Full Text]
-
Bandeira-Melo, C., Woods, L. J., Phoofolo, M., Weller, P. F.
(2002). Intracrine Cysteinyl Leukotriene Receptor-mediated Signaling of Eosinophil Vesicular Transport-mediated Interleukin-4 Secretion. JEM
196: 841-850
[Abstract]
[Full Text]
-
Han, B., Luo, G., Shi, Z.-Z., Barrios, R., Atwood, D., Liu, W., Habib, G. M., Sifers, R. N., Corry, D. B., Lieberman, M. W.
(2002). {gamma}-Glutamyl Leukotrienase, a Novel Endothelial Membrane Protein, Is Specifically Responsible for Leukotriene D4 Formation in Vivo. Am. J. Pathol.
161: 481-490
[Abstract]
[Full Text]
-
Maekawa, A., Austen, K. F., Kanaoka, Y.
(2002). Targeted Gene Disruption Reveals the Role of Cysteinyl Leukotriene 1 Receptor in the Enhanced Vascular Permeability of Mice Undergoing Acute Inflammatory Responses. J. Biol. Chem.
277: 20820-20824
[Abstract]
[Full Text]
-
Mellor, E. A., Austen, K. F., Boyce, J. A.
(2002). Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4-regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists. JEM
195: 583-592
[Abstract]
[Full Text]